Integra LifeSciences Holdings Price to Book Ratio 2010-2023 | IART
Historical price to book ratio values for Integra LifeSciences Holdings (IART) over the last 10 years. The current price to book ratio for Integra LifeSciences Holdings as of March 27, 2024 is 1.66.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Integra LifeSciences Holdings Price/Book Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | Book Value per Share | Price to Book Ratio |
2024-03-27 | 34.83 | 1.71 | |
2023-12-31 | 43.55 | $20.31 | 2.14 |
2023-09-30 | 38.19 | $19.96 | 1.91 |
2023-06-30 | 41.13 | $20.69 | 1.99 |
2023-03-31 | 57.41 | $20.45 | 2.81 |
2022-12-31 | 56.07 | $21.57 | 2.60 |
2022-09-30 | 42.36 | $20.65 | 2.05 |
2022-06-30 | 54.03 | $19.89 | 2.72 |
2022-03-31 | 64.26 | $19.43 | 3.31 |
2021-12-31 | 66.99 | $19.89 | 3.37 |
2021-09-30 | 68.48 | $19.26 | 3.55 |
2021-06-30 | 68.24 | $18.62 | 3.66 |
2021-03-31 | 69.09 | $18.10 | 3.82 |
2020-12-31 | 64.92 | $17.96 | 3.61 |
2020-09-30 | 47.22 | $16.59 | 2.85 |
2020-06-30 | 46.99 | $16.01 | 2.94 |
2020-03-31 | 44.67 | $15.82 | 2.82 |
2019-12-31 | 58.28 | $16.50 | 3.53 |
2019-09-30 | 60.07 | $16.14 | 3.72 |
2019-06-30 | 55.85 | $16.62 | 3.36 |
2019-03-31 | 55.72 | $16.35 | 3.41 |
2018-12-31 | 45.10 | $16.15 | 2.79 |
2018-09-30 | 65.87 | $16.03 | 4.11 |
2018-06-30 | 64.41 | $15.81 | 4.07 |
2018-03-31 | 55.34 | $12.67 | 4.37 |
2017-12-31 | 47.86 | $12.28 | 3.90 |
2017-09-30 | 50.48 | $11.65 | 4.33 |
2017-06-30 | 54.51 | $11.55 | 4.72 |
2017-03-31 | 42.13 | $11.33 | 3.72 |
2016-12-31 | 42.90 | $11.24 | 3.82 |
2016-09-30 | 41.28 | $11.03 | 3.74 |
2016-06-30 | 39.89 | $10.65 | 3.75 |
2016-03-31 | 33.68 | $10.47 | 3.22 |
2015-12-31 | 33.89 | $10.25 | 3.31 |
2015-09-30 | 29.78 | $9.88 | 3.01 |
2015-06-30 | 30.59 | $10.75 | 2.85 |
2015-03-31 | 28.00 | $10.47 | 2.67 |
2014-12-31 | 24.63 | $10.76 | 2.29 |
2014-09-30 | 22.54 | $10.54 | 2.14 |
2014-06-30 | 21.37 | $10.58 | 2.02 |
2014-03-31 | 20.88 | $10.43 | 2.00 |
2013-12-31 | 21.67 | $10.70 | 2.03 |
2013-09-30 | 18.28 | $8.90 | 2.05 |
2013-06-30 | 16.63 | $9.20 | 1.81 |
2013-03-31 | 17.71 | $9.09 | 1.95 |
2012-12-31 | 17.70 | $9.26 | 1.91 |
2012-09-30 | 18.66 | $9.75 | 1.91 |
2012-06-30 | 16.88 | $9.39 | 1.80 |
2012-03-31 | 15.75 | $9.47 | 1.66 |
2011-12-31 | 14.00 | $9.18 | 1.53 |
2011-09-30 | 16.24 | $9.23 | 1.76 |
2011-06-30 | 21.71 | $9.46 | 2.30 |
2011-03-31 | 21.53 | $9.25 | 2.33 |
2010-12-31 | 21.48 | $8.76 | 2.45 |
2010-09-30 | 17.92 | $8.35 | 2.15 |
2010-06-30 | 16.80 | $7.94 | 2.12 |
2010-03-31 | 19.90 | $7.92 | 2.51 |
2009-12-31 | 16.74 | $7.78 | 2.15 |
2009-09-30 | 15.51 | $7.56 | 2.05 |
2009-06-30 | 12.04 | $7.09 | 1.70 |
2009-03-31 | 11.23 | $6.66 | 1.69 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $2.653B | $1.542B |
Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $216.898B | 26.41 |
Intuitive Surgical (ISRG) | United States | $140.939B | 87.97 |
Edwards Lifesciences (EW) | United States | $56.173B | 37.22 |
DexCom (DXCM) | United States | $53.945B | 92.67 |
IQVIA Holdings (IQV) | United States | $44.965B | 26.67 |
IDEXX Laboratories (IDXX) | United States | $44.087B | 52.69 |
Alcon (ALC) | Switzerland | $40.745B | 30.05 |
STERIS (STE) | Ireland | $21.889B | 25.91 |
Waters (WAT) | United States | $20.016B | 28.77 |
Hologic (HOLX) | United States | $17.880B | 19.73 |
SONOVA HOLDING (SONVY) | Switzerland | $16.949B | 0.00 |
ShockWave Medical (SWAV) | United States | $11.820B | 81.67 |
Sysmex ADR (SSMXY) | Japan | $11.167B | 35.03 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $11.097B | 13.70 |
Teleflex (TFX) | United States | $10.183B | 16.00 |
Penumbra (PEN) | United States | $8.548B | 105.68 |
Masimo (MASI) | United States | $7.442B | 41.74 |
Globus Medical (GMED) | United States | $6.988B | 22.16 |
Glaukos (GKOS) | United States | $4.438B | 0.00 |
Integer Holdings (ITGR) | United States | $3.726B | 23.88 |
LivaNova (LIVN) | United Kingdom | $2.935B | 19.36 |
Elekta AB (EKTAY) | Sweden | $2.902B | 19.91 |
Inari Medical (NARI) | United States | $2.673B | 461.10 |
TransMedics (TMDX) | United States | $2.436B | 0.00 |
PROCEPT BioRobotics (PRCT) | United States | $2.366B | 0.00 |
Nihon Kohden (NHNKY) | Japan | $2.330B | 19.71 |
Tandem Diabetes Care (TNDM) | United States | $2.211B | 0.00 |
Alphatec Holdings (ATEC) | United States | $1.850B | 0.00 |
RxSight (RXST) | United States | $1.818B | 0.00 |
Veracyte (VCYT) | United States | $1.545B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.943B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.905B | 16.74 |
Paragon 28 (FNA) | United States | $0.849B | 0.00 |
Artivion (AORT) | United States | $0.846B | 97.76 |
Silk Road Medical (SILK) | United States | $0.745B | 0.00 |
Treace Medical Concepts (TMCI) | United States | $0.709B | 0.00 |
OPKO Health (OPK) | United States | $0.704B | 0.00 |
SiBone (SIBN) | United States | $0.628B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.619B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.552B | 18.74 |
IRadimed (IRMD) | United States | $0.539B | 31.32 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.509B | 0.00 |
Nevro (NVRO) | United States | $0.494B | 0.00 |
Pulse Biosciences (PLSE) | United States | $0.454B | 0.00 |
CVRx (CVRX) | United States | $0.378B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.367B | 12.37 |
NeuroPace (NPCE) | United States | $0.350B | 0.00 |
AxoGen (AXGN) | United States | $0.326B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.269B | 0.00 |
Sight Sciences (SGHT) | United States | $0.249B | 0.00 |
Accuray (ARAY) | United States | $0.235B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.226B | 0.00 |
908 Devices (MASS) | United States | $0.217B | 0.00 |
AngioDynamics (ANGO) | United States | $0.215B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.207B | 0.00 |
Semler Scientific (SMLR) | United States | $0.200B | 10.77 |
Inogen (INGN) | United States | $0.181B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.176B | 0.00 |
Neuronetics (STIM) | United States | $0.142B | 0.00 |
Yubo Biotech (YBGJ) | China | $0.122B | 0.00 |
Delcath Systems (DCTH) | United States | $0.102B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.098B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.095B | 0.00 |
Envoy Medical (COCH) | United States | $0.079B | 0.00 |
Hyperfine (HYPR) | United States | $0.077B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.073B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.072B | 0.00 |
SEP Acquisition (SEPA) | United States | $0.071B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.065B | 133.00 |
Vicarious Surgical (RBOT) | United States | $0.056B | 0.00 |
Vasomedical (VASO) | United States | $0.056B | 4.29 |
Autonomix Medical (AMIX) | $0.055B | 0.00 | |
InspireMD (NSPR) | Israel | $0.053B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.048B | 0.00 |
ReWalk Robotics (LFWD) | Israel | $0.046B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.042B | 0.00 |
DarioHealth (DRIO) | United States | $0.041B | 0.00 |
LENSAR (LNSR) | United States | $0.040B | 0.00 |
Pixie Dust Technologies (PXDT) | Japan | $0.040B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.036B | 0.00 |
Spectral AI (MDAI) | United States | $0.036B | 0.00 |
Precision Optics (POCI) | United States | $0.036B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.027B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.023B | 0.00 |
PAVmed (PAVM) | United States | $0.019B | 0.00 |
PetVivo Holdings (PETV) | United States | $0.017B | 0.00 |
NexGel (NXGL) | United States | $0.016B | 0.00 |
Check-Cap (CHEK) | Israel | $0.014B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.014B | 0.00 |
Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.012B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.011B | 0.00 |
QT Imaging Holdings (QTI) | United States | $0.008B | 0.00 |
Avinger (AVGR) | United States | $0.005B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.004B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
Venus Concept (VERO) | Canada | $0.004B | 0.00 |
Nuwellis (NUWE) | United States | $0.003B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
Tenon Medical (TNON) | United States | $0.002B | 0.00 |
Dynatronics (DYNT) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.000B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |